Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery
Imiquimod (IMQ) is a potent immune response modifier with antiviral and antitumor properties. IMQ’s low aqueous solubility and unsatisfactory cutaneous permeability limit its formulation into effective dosage forms. This work aimed to develop IMQ-loaded microemulsions (MEs) based on phospholipids an...
Main Authors: | Eleni Panoutsopoulou, Jarmila Zbytovská, Kateřina Vávrová, Georgios Paraskevopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/5/515 |
Similar Items
-
The Complementary Role of ToF-SIMS in the Assessment of Imiquimod Permeated into the Skin from a Microemulsion Dosage Form
by: Mohammed Hussain Al-Mayahy, et al.
Published: (2019-12-01) -
Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model
by: Mehwish Jabeen, et al.
Published: (2020-08-01) -
Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-induced Psoriasis-like Dermatitis in Mice
by: Jiun-Wen Guo, et al.
Published: (2020-05-01) -
Phospholipid-Based Topical Nano-Hydrogel of Mangiferin: Enhanced Topical Delivery and Improved Dermatokinetics
by: Faisal K. Alkholifi, et al.
Published: (2023-02-01) -
Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges
by: Zouhair Ait-Touchente, et al.
Published: (2023-05-01)